These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20336156)

  • 1. Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors.
    Zeltner N; Kohlbrenner E; Clément N; Weber T; Linden RM
    Gene Ther; 2010 Jul; 17(7):872-9. PubMed ID: 20336156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.
    Wang XS; Khuntirat B; Qing K; Ponnazhagan S; Kube DM; Zhou S; Dwarki VJ; Srivastava A
    J Virol; 1998 Jul; 72(7):5472-80. PubMed ID: 9621003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the production efficiency and titration of various recombinant adeno-associated viruses.
    Nam YR; Kim SJ; Lee B; Chang JW; Joo CH; Kim YK; Lee H
    Oncol Rep; 2004 Oct; 12(4):761-6. PubMed ID: 15375497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
    Dong JY; Fan PD; Frizzell RA
    Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectivity Assessment of Recombinant Adeno-Associated Virus and Wild-Type Adeno-Associated Virus Exposed to Various Diluents and Environmental Conditions.
    Tomono T; Hirai Y; Chono H; Mineno J; Ishii A; Onodera M; Tamaoka A; Okada T
    Hum Gene Ther Methods; 2019 Aug; 30(4):137-143. PubMed ID: 31317781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
    Yan Z; Zak R; Zhang Y; Engelhardt JF
    J Virol; 2005 Jan; 79(1):364-79. PubMed ID: 15596830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.
    Kube DM; Ponnazhagan S; Srivastava A
    J Virol; 1997 Oct; 71(10):7361-71. PubMed ID: 9311814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-free production and column purification of adeno-associated virus type 5.
    Smith RH; Ding C; Kotin RM
    J Virol Methods; 2003 Dec; 114(2):115-24. PubMed ID: 14625046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
    Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
    Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication competent helper functions for recombinant AAV vector generation.
    Cao L; During M; Xiao W
    Gene Ther; 2002 Sep; 9(18):1199-206. PubMed ID: 12215886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
    Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
    J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant adeno-associated virus vector related impurities].
    Diao Y; Wang Q; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New recombinant serotypes of AAV vectors.
    Gao G; Vandenberghe LH; Wilson JM
    Curr Gene Ther; 2005 Jun; 5(3):285-97. PubMed ID: 15975006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
    Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N
    J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.